Stories of Hope: How PAN’s Partnership with ZERO has touched the lives of Thousands
In fall of 2013, the PAN Foundation and ZERO - The End of Prostate Cancer entered into a partnership aimed at providing not only a reliable financial assistance resource for underinsured advanced prostate cancer patients, but also best-in-class educational materials to support these men and their families through the continuum of their diagnosis. Eight months and more than 5,000 approved grants later, we are thrilled to continue our partnership in 2014 and beyond.
“The financial impact of my diagnosis brings tears to my eyes,” explained PAN/ZERO patient, Chris, “the medical costs started to come in – travel expenses, hotel, meals, co-pays, co-insurance, deductibles, on and on - it was difficult to breathe at times… I was approved for a grant just recently, and the relief… it was just great to find out that I had that kind of assistance now available to me.”
“Every day, our partnership with the Patient Access Network Foundation is giving hope and precious time to families impacted by prostate cancer,” Jamie Bearse, ZERO’s President & CEO said. “Countless lives can be saved when organizations work together to achieve a common goal. We’re proud of our joint efforts and the progress we’re making toward creating Generation ZERO – the first generation of men free from prostate cancer.”
“Financial assistance is too often mCRPC patients’ only route for initiating or continuing treatments that they’re told are their only hope,” explained Korab Zuka, PAN Foundation Vice President of External Relations and Patient Services. “We want to make sure that these patients not only have a reliable financial assistance resource, but also that they and their families have access to the most up-to-date educational resources available for their diagnosis. This first-of-its-kind partnership encourages a more holistic approach to patient assistance, which we hope will lead to better patient outcomes.”
For more information on PAN’s co-pay and travel assistance programs for metastatic castrate resistant prostate cancer, click here.
To access ZERO’s newest resources for advanced prostate cancer patients, click here.